The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

[
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings. Read More
https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2194795164_7c52a5-e1738781450840.jpg?resize=1200,600
https://fortune.com/2025/02/05/pfizer-merck-promising-prognosis-investors-faulty-forecasts/


Jeffrey Sonnenfeld, Steven Tian